Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,500 | 31 | 61.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $20,932 | 29 | 36.1% |
| Food and Beverage | $963.00 | 53 | 1.7% |
| Travel and Lodging | $509.68 | 24 | 0.9% |
| Education | $16.35 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $31,084 | 80 | $0 (2021) |
| Organon Llc | $26,744 | 53 | $0 (2024) |
| ABBVIE INC. | $40.85 | 2 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $21.91 | 1 | $0 (2023) |
| Myovant Sciences Inc. | $16.35 | 1 | $0 (2021) |
| Hologic, LLC | $14.04 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,887 | 7 | Organon Llc ($2,846) |
| 2023 | $5,720 | 13 | Organon LLC ($5,698) |
| 2022 | $12,643 | 26 | Organon LLC ($12,643) |
| 2021 | $6,967 | 13 | Organon LLC ($5,557) |
| 2020 | $1,443 | 5 | Merck Sharp & Dohme Corporation ($1,443) |
| 2019 | $12,648 | 30 | Merck Sharp & Dohme Corporation ($12,648) |
| 2018 | $9,380 | 25 | Merck Sharp & Dohme Corporation ($9,366) |
| 2017 | $6,233 | 19 | Merck Sharp & Dohme Corporation ($6,233) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: WOMENS HEALTH | ||||||
| 11/15/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: WOMENS HEALTH | ||||||
| 07/17/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: ETONOGESTREL | ||||||
| 07/11/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 07/11/2024 | Organon Llc | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| 07/11/2024 | Organon Llc | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $36.18 | General |
| Category: ETONOGESTREL | ||||||
| 07/11/2024 | Organon Llc | — | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $36.18 | General |
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $32.75 | General |
| Category: ETONOGESTREL | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: ETONOGESTREL | ||||||
| 08/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: ETONOGESTREL | ||||||
| 07/13/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 07/13/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $15.72 | General |
| Category: ETONOGESTREL | ||||||
| 07/06/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $35.37 | General |
| Category: ETONOGESTREL | ||||||
| 07/03/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 06/28/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $65.63 | General |
| Category: ETONOGESTREL | ||||||
| 06/22/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: ETONOGESTREL | ||||||
| 04/19/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: HORMONE THERAPY | ||||||
| 02/17/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 02/17/2023 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $14.41 | General |
| Category: ETONOGESTREL | ||||||
| 11/10/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $1,375.00 | General |
| Category: ETONOGESTREL | ||||||
| 11/10/2022 | Organon LLC | NEXPLANON (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $17.50 | General |
| Category: ETONOGESTREL | ||||||
| 11/05/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: ETONOGESTREL | ||||||
| 11/05/2022 | Organon LLC | — | Food and Beverage | In-kind items and services | $9.30 | General |
| 10/19/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: ETONOGESTREL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 35 | $21,516 | $924.18 |
| 2022 | 2 | 28 | 39 | $20,790 | $1,134 |
| 2021 | 1 | 11 | 14 | $1,400 | $342.05 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 16 | $19,616 | $528.16 | 2.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 14 | 19 | $1,900 | $396.02 | 20.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 16 | 24 | $2,400 | $583.11 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 15 | $18,390 | $551.29 | 3.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 11 | 14 | $1,400 | $342.05 | 24.4% |
About Dr. Sebhat Afework, MD
Dr. Sebhat Afework, MD is a Obstetrics & Gynecology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891821666.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sebhat Afework, MD has received a total of $57,921 in payments from pharmaceutical and medical device companies, with $2,887 received in 2024. These payments were reported across 138 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,500).
As a Medicare-enrolled provider, Afework has provided services to 68 Medicare beneficiaries, totaling 88 services with total Medicare billing of $2,401. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Los Angeles, CA
- Active Since 02/26/2007
- Last Updated 12/01/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1891821666
Products in Payments
- NEXPLANON (Drug) $50,872
- Nexplanon (Drug) $5,504
- LILETTA (Drug) $40.85
- MYFEMBREE (Drug) $38.26
- ATV (Device) $14.04
- NUVARING (Drug) $8.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Los Angeles
Ramon Yera, Md, MD
Obstetrics & Gynecology — Payments: $858,979
Malcolm Munro, Md, MD
Obstetrics & Gynecology — Payments: $579,635
Ms. Aela Paiz, Do, DO
Obstetrics & Gynecology — Payments: $124,098
Nicole Bender, Md, MD
Obstetrics & Gynecology — Payments: $47,062
Dr. Karen Mann, M.d, M.D
Obstetrics & Gynecology — Payments: $44,510
Christopher Tarnay, Md, MD
Obstetrics & Gynecology — Payments: $43,780